Alkermes

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.

CEO

Richard F. Pops

CEORichard F. Pops

Employees

1,800

Employees1,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2011

Founded2011

Employees

1,800

Employees1,800

ALKS Key Statistics

Market cap

5.18B

Market cap5.18B

Price-Earnings ratio

15.13

Price-Earnings ratio15.13

Dividend yield

—

Dividend yield—

Average volume

1.71M

Average volume1.71M

High today

$32.02

High today$32.02

Low today

$31.29

Low today$31.29

Open price

$31.63

Open price$31.63

Volume

1.56M

Volume1.56M

52 Week high

$36.45

52 Week high$36.45

52 Week low

$25.17

52 Week low$25.17

ALKS News

Simply Wall St 11h

What Do Recent Gains Mean for Alkermes Stock Value in 2025?

Are you eyeing Alkermes and wondering what your next move should be? You are not alone. Investors have watched Alkermes quietly rack up impressive gains, with t...

Analyst ratings

76%

of 17 ratings

Buy

76.5%

Hold

23.5%

Sell

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.